Skip to main content
logo
Cellyan Biotechnology Co., Ltd (HKPD)
NASDAQ: HKPD · Real-Time Price · USD
0.4096
-0.0329 (-7.44%)
At close: Aug 3, 2026, 4:00 PM EDT
0.4099
+0.0003 (0.07%)
After-hours: Aug 3, 2026, 7:03 PM EDT

Cellyan Biotechnology Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Mar '25 Mar '24 Mar '23
Market Cap
1012--
Market Cap Growth
-18.98%---
Enterprise Value
9.7911.2500
Last Close Price
0.411.08--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Mar '25 Mar '24 Mar '23
PS Ratio
0.610.58--
PB Ratio
0.952.38--
P/TBV Ratio
0.872.25--
P/FCF Ratio
-23.79--
P/OCF Ratio
-20.87--

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Mar '25 Mar '24 Mar '23
EV/Sales Ratio
0.600.55--
EV/EBITDA Ratio
22.749.33--
EV/EBIT Ratio
-85.20--
EV/FCF Ratio
-22.53--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Mar '25 Mar '24 Mar '23
Debt / Equity Ratio
0.280.300.300.46
Debt / EBITDA Ratio
5.281.970.820.39
Debt / FCF Ratio
-4.76-0.43
Net Debt / Equity Ratio
-0.04-0.130.350.28
Net Debt / EBITDA Ratio
-0.48-0.520.580.10
Net Debt / FCF Ratio
0.42-1.26-3.280.10
Asset Turnover
1.722.252.763.69
Inventory Turnover
25.8723.9723.3651.43
Quick Ratio
2.732.801.761.00
Current Ratio
2.932.992.461.08
Return on Equity (ROE)
-13.85%-0.59%54.96%170.56%
Return on Assets (ROA)
-6.31%-1.09%23.21%29.96%
Return on Invested Capital (ROIC)
-12.19%-1.96%43.30%135.79%
Return on Capital Employed (ROCE)
-10.08%2.20%50.67%121.84%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Mar '25 Mar '24 Mar '23
FCF Yield
-4.20%--
Buyback Yield / Dilution
-19.69%-38.56%-7.64%-
Total Shareholder Return
-19.69%-38.56%-7.64%-
SEC Filings: 10-K · 10-Q